Dr. Markus Grompe is a leader in the field of stem cell research with a focus on cell and gene therapy for genetic liver diseases. His laboratory research has focused on the use of in vivo selection to enhance cell transplantation, and he discovered and developed a method to enable the production of human hepatocytes.Markus is a Professor at the Papé Family Pediatric Research Institute at Oregon Health and Science University in Portland, Oregon. In addition to founding Ambys Medicines, he is also a founder of Yecuris Corporation. He has published over 260 peer-reviewed articles, the majority of which are on the topics of liver biology and hepatic disease. He holds 10 issued patents, including the seminal patent on liver humanization in mice.Markus received his medical degree at the University of Ulm in Germany and trained as a pediatrician at Oregon Health and Science University. He completed a fellowship in molecular genetics at Baylor College of Medicine in Houston, Texas.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Ambys Medicines | Co-Founder & Chief Scientific Officer | Feb 1, 2018 | — | Detail |